EllieMD Dihexa BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification FDA Peptide Update: Category 2 Removals Explained RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica FDA Category 2 Update: The 5 Peptides Still Facing Heavy Review As excitement builds around peptides potentially moving off the FDA Category 2 list, it's important to understand one key reality: Not DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs